Upgrade to SI Premium - Free Trial

Bernstein Downgrades Teva Pharma (TEVA) to Market Perform

August 4, 2017 8:02 AM
Bernstein downgraded Teva Pharma (NYSE: TEVA) from Outperform to Market ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change Downgrades

Next Articles